| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.23 | 3e-11 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.18 | 7e-08 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-06 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.15 | 7e-06 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-06 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.22 | 3e-05 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.21 | 7e-05 |